Skip to main content
OpenTrials

Clinical trial condition

DS Stage III Plasma Cell Myeloma

Explore clinical trials studying DS Stage III Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

DS Stage III Plasma Cell Myeloma trial results

Completed

S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

NCT01668719

Conditions
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma
Locations
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 417 locations
View Trial Details
Completed

Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT01605032

Conditions
Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • NYU Cancer Institute New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
View Trial Details
Completed

Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma

NCT00088855

Conditions
DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma
Locations
  • Palo Alto Medical Foundation-Camino Division Mountain View, California, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details

Related conditions